Dopamine crosslinked gelatin liquid absorbing hemostatic sponge and preparation method thereof

A hemostatic sponge and dopamine technology, applied in the field of medical devices, can solve the problems of poor biocompatibility, troublesome operation, affecting the field of operation, etc., and achieve the effects of low requirements for instruments and equipment, industrialized production, and easy operation of the process.

Active Publication Date: 2016-05-11
SHANDONG ACADEMY OF PHARMACEUTICAL SCIENCES
View PDF7 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, the liquid-absorbing hemostatic dressings used in clinical surgery usually include medical absorbent cotton or fiber, acetalized polyvinyl alcohol sponge and acetalized gelatin sponge, but the above dressings usually have the following disadvantages: medical absorbent cotton or fiber contains fiber filaments or fiber heads, During the operation, the fiber shedding often affects the surgical field of view and is not conducive to wound healing; t...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dopamine crosslinked gelatin liquid absorbing hemostatic sponge and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0029] The present invention also includes the preparation method of the gelatin liquid-absorbing hemostatic sponge cross-linked by dopamine, comprising the following steps:

[0030] Dissolving Pluronic, succinic anhydride, 4-dimethylaminopyridine and triethylamine in an organic solvent, stirring and reacting at 20 to 30°C for 25 to 35 hours, and evaporating under reduced pressure to remove the organic solvent to obtain a residue; The organic solvent is 1,4-dioxane, methylene chloride or ethyl acetate; the mass volume ratio of the pluronic, succinic anhydride, 4-dimethylaminopyridine, triethylamine and organic solvent is 90 ~110g:1g:1~1.5g:0.5~0.8g:350~450ml;

[0031] will step Add chloroform to the obtained residue to dissolve, add diethyl ether under slow stirring to form a precipitate, collect the precipitate by filtration, repeat this step for 3 to 5 times to obtain a white solid, and vacuum dry the obtained white solid at 20 to 30°C , obtain carboxylated pluronic; t...

Embodiment 1

[0048] Dissolve 90g of Pluronic P407, 1g of succinic anhydride, 1g of 4-dimethylaminopyridine and 0.5g of triethylamine in 350ml of 1,4-dioxane, stir and react at 20°C for 25 hours, evaporate under reduced pressure to remove 1 ,4-dioxane to give the residue;

[0049] will step The resulting residue was dissolved in 10 ml of chloroform, and 500 ml of ether was added under slow stirring to form a precipitate. The resulting precipitate was collected by filtration, and the process was repeated for 3 times to obtain a white solid. The resulting white solid was vacuum-dried at 20°C to obtain Carboxylated Pluronic P407;

[0050] Step 45g The resulting carboxylated Pluronic P407, 15g of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride were dissolved in 300ml of MES buffer, stirred for 20 minutes and then added with 15g of N-hydroxysuccinimide , after stirring and reacting for 20 minutes, add 45g of gelatin, stir and react at 40°C for 25 hours to obtain a reaction ...

Embodiment 2

[0055] Dissolve 110g of Pluronic F68, 1g of succinic anhydride, 1.5g of 4-dimethylaminopyridine and 0.8g of triethylamine in 450ml of dichloromethane, stir and react at 30°C for 35 hours, evaporate the dichloromethane under reduced pressure to obtain leftovers;

[0056] will step The resulting residue was dissolved in 15 ml of chloroform, and 1500 ml of ether was added under slow stirring to form a precipitate. The resulting precipitate was collected by filtration, and this step was repeated for 5 times to obtain a white solid, which was vacuum-dried at 30°C to obtain Carboxylated Pluronic F68;

[0057] Step 80g The resulting carboxylated Pluronic F68, 20g of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride were dissolved in 600ml of MES buffer, stirred for 40 minutes and then added with 20g of N-hydroxysuccinimide After stirring and reacting for 40 minutes, 60 g of gelatin was added, and stirred and reacted at 40° C. for 35 hours to obtain a reaction liqu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a dopamine crosslinked gelatin liquid absorbing hemostatic sponge and a preparation method thereof. The preparation method of the hemostatic sponge comprises the following steps: grafting carboxylated pluronic to gelatin to obtain super-hydrophilic modified gelatin, taking dopamine hydrochloride as the crosslinking agent, oxidizing super-hydrophilic modified gelatin in the presence of a strong oxidant, adding medical auxiliary materials, and carrying out mechanical foaming and freeze-drying to obtain the sponge like gelatin liquid absorbing hemostatic dressing. The provided dopamine crosslinked gelatin liquid absorbing hemostatic sponge can be used as a sponge like medical dressing, which has a sponge like appearance and many small pores. The dressing is soft, can be directly used without infiltration, has a high biocompatibility, can be used with thrombin together, can be completely and biologically decomposed, is capable of absorbing liquid quickly, stopping bleeding immediately, and adhering on the wounds, is suitable for absorbing liquid and stopping bleeding in surgeries, and is especially suitable for absorbing liquid in the surgery of eyes.

Description

technical field [0001] The invention relates to the technical field of medical devices, in particular to a dopamine-crosslinked gelatin liquid-absorbing hemostatic sponge and a preparation method thereof. Background technique [0002] At present, the liquid-absorbing hemostatic dressings used in clinical surgery usually include medical absorbent cotton or fiber, acetalized polyvinyl alcohol sponge and acetalized gelatin sponge, but the above dressings usually have the following disadvantages: medical absorbent cotton or fiber contains fiber filaments or fiber heads, During the operation, the fiber shedding often affects the surgical field of view, and is also not conducive to wound healing; the raw material polyvinyl alcohol of the acetalized polyvinyl alcohol sponge is a chemically synthesized raw material, and its biocompatibility is poor, and the acetalized polyvinyl alcohol sponge and acetalized polyvinyl alcohol sponge Aldehyde gelatin sponges usually use aldehyde cross...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L15/32A61L15/42A61L15/44A61L15/20
CPCA61L15/20A61L15/32A61L15/425A61L15/44A61L2300/204A61L2300/216A61L2400/04
Inventor 王晓晨郈秀菊李俊起李红梅张素文朱肖杰朱小敏王传栋夏毅然孟建文
Owner SHANDONG ACADEMY OF PHARMACEUTICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap